Postgraduate Course in Cardiometabolic Medicine 2024

Tue 30.04 – Fri 03.05.2024

City: London

Type of event: on site


Dear Colleagues

It is a pleasure to announce a truly innovative Postgraduate Course in Cardiometabolic Medicine, a timely and highly acclaimed educational programme conceived by Zurich Heart House – London Heart House, King’s College, and Royal Brompton & Harefield Hospitals, which will address an unmet educational need.

Cardiometabolic disorders represent a cluster of interrelated risk factors, primarily dyslipidemia, hypertension, elevated fasting blood glucose, obesity and non-alcoholic steatohepatitis. A combination of several of these risk factors massively increases the incidence and mortality of coronary heart disease and stroke. The strong association between metabolic disorders and cardiovascular health delivers a compelling reason to improve awareness of this cluster by identifying the risk factors and inducing targeted interventions.

The Postgraduate Course in Cardiometabolic Medicine consists of a four-day programme. State of the art lectures alternate with a great variety of interactive sessions, including workshops, rapid fire sessions and hands-on imaging sessions.

The course offers a unique opportunity to become one of the first experts in the seminal area of cardiometabolic medicine. We are looking forward to receiving your application and meeting you in London.


Andrew Krentz
Thomas F. Lüscher
Naveed Sattar
John Deanfield
Mahmud Barbir
Michael Papadakis

Scientific Programme

Tuesday, April 30th, 2024 (UK time)

Venue: The Royal Society of Medicine

08:30 | Welcome Session
08:30Welcome by the course directors 
08:45Course concept and structureEleanor Wicks, Oxford 
09:00 | Session 1: Obesity I- Causes and mechanisms
Chairs: John E. Deanfield & Michael Papadakis
09:00Is obesity a disease? If so,
how do we diagnose it?
Francesco Rubino, London 
09:40The gut microbiome: a new
cardiovascular risk factor
Thomas F. Lüscher, London 
10:00What links adiposity to CVD?Marc Donath, Basel 
10:20Panel discussionNaveed Sattar, Glasgow 
11:30 | Session 2: Obesity II – Management
Chairs: Naveed Sattar & Marc Donath
11:30Bariatric surgery: pros is there still
a role?
Barbara McGowan, London 
11:50Behavioural management: NutritionMichael Lean, Glasgow 
12:10Behavioural management: Exercise &
sports – ESC guidelines 2020 and
Michael Papadakis, London 
12:30Medical management of obesity:
GLP-1/GIP agonists
Michael Papadakis, London 
12:50Panel discussion 
14:30 | Session 3: ASCVD Assessment I
Chairs: Mahmoud Barbir & Thomas F. Lüscher
14:30Inflammation and plaque formationChristian Weber, Munich 
14:50LDL-C and cardiovascular disease:
Why is lower better?
Lale Tokgozolu, Ankara 
15:10Cardiovascular risk assessment:
Frank Visseren, Utrecht 
15:30Lifetime risk: CVD prevention –
personal and national strategy
John E. Deanfield, London 
15:50Panel discussion 
17:00 | Case-based interactive seminars
How to assess adiposity:
Clinical, MRI and beyond
Geltrude Mingrone, London 
How to manage obesityBarbara McGowan, London 
18:00 | End of day 1

Wednesday, May 1st, 2024
09:00 | Session 4: ASCVD Assessment II
Chairs: John Chapman & Christian Heiss
09:00Multimodality imaging to assess ASCVDChrsitoph Gräni, Bern 
09:20CT-based coronary imaging for CV risk
Charalambos Antoniades,
09:40Novel lipoproteins: Lipoprotein(a)Francois Mach, Geneva 
10:00Are triglycerides a cardiovascular
risk factor?
Borge Nordestgaard,
10:20Panel discussion 
11:30 | Session 5: ASCVD – Management
Chairs: Jürg H. Beer & Francois Mach
11:30Secondary hypertension: an
underrecognized condition
Tomasz Guzik, Edinburgh 
11:50Unsaturated fatty acids and
CV risk reduction
John Chapman, Paris 
12:10Personalized LDL-C management:
From pills to nucleic acids
Kausik Ray, London 
12:30Arterial hypertension: from drugs to
Vikas Kapil, London 
12:50Panel discussion 
14:30 | Hands-on seminars
Practical lipid apheresisMahmoud Barbir, London/
Jo Senior, Harefield/
Alison Pottle, Harefield/
Stefan Bornstein, Dresden
Assessing vascular structure and
function – practical demonstrations
Christian Heiss, Guildford 
17:00 | Session 6 ASCVD: Platelets and coagulation
Chairs:Thomas F. Lüscher & Shouvik Haldar
17:00Intravascular thrombus formation:
platelets and intrinsic/extrinsic system
Jürg H. Beer, Baden 
17:20Platelet inhibition: DAPT or SAPT?
the 2023 ESC guidelines on ACS
Robert Byrne, Dublin 
17:40Novel oral anticoagulants in VTE and AF:
the ESC Guidelines and beyond
A. John Camm, London 
18:00Panel discussion 

Thursday, May 2nd, 2024
09:00 | Session 7: Diabetes mellitus (DM)
Chairs: Andrew Krentz & Thimotheus Speer
09:00Pathogenesis of Type 2 DMMarc Donath, Basel 
09:20Diabetes Type 2 and CVD
beyond glucocentricity
Stephan Jacob, Villingen 
09:40Management of CVD risk
in type 2 diabetes –
the 2023 ESC Diabetes guidelines
Dirk Müller-Wieland, Aachen 
10:00Panel discussion 
11:00 | Session 8: Nephrology – Chronic kidney disease (CKD) –
Causes & Mechanisms
Chairs: Ian Wilkinson & Andrew Krentz
11:00Causes and clinical presentation of
Britta George. Zurich 
11:20CKD and cardiovascular riskThimoteus Speer, Frankfurt 
11:40Albuminuria, eGFR slopes and
outcomes: impact of pharmacotherapy
David Wheeler, London 
12:00Panel discussion
12:30 Industry Sponsored Symposium:
Challenging the Status Quo in Cardiorenal Management

This is a promotional symposium sponsored and organised by AstraZeneca, intended for GB HCPs only
14:00 | Session 9: Nephrology – Chronic kidney disease (CKD) – Management
Chairs: Stephan Jacob & Britta George
14:00SGLT2i and GLP1-RA bin CKD and
DKD – the 4 pillar approach
Christoph Wanner, Würzburg 
14:20Non-steroidal MR antagonistsBertram Pitt, An Arbor (remote) 
14:40Management of hyperkalemia in
Joao Pedro Ferreira, Porto 
15:00Panel discussion 
16:00 | Case-based interactive seminars
Managing type 2 diabetes
and CVD risk
Stephan Jacob, Villingen 
Managing patients with CKDTimo Speer, Frankfurt 
17:00 | End of day 3

Friday, May 3rd, 2024

11:30 | Session 10: Metabolic dysfunction-associated steatotic liver disease (MASLD) and Endocrinology
Chairs: Andrew Krentz & Kamlesh Khunti
09:00Screening and diagnosis of MASLDPhilip Newsome, Birmingham 
09:20Extrahepatic cardiometabolic disease
associations with MASLD
Kevin Moore, London 
09:40Management of MASLDWilliam Alazawi, London 
10:00Cardiovascular risk in endocrine
Adrian Heald, Manchester 
10:20Sex hormonesAndrew Krentz, London 
10:40Panel discussion 
11:30 | Session 11: Amyloid heart disease
Chairs: Rakesh Sharma & Eleanor Wicks
11:30The spectrum of amyloid heart diseaseAshutosh Wechalekar, London 
11:50Diagnosis and management of
cardiac amyloidosis
Roy S. Gardner, Glasgow 
12:10Panel discussion 
13:30 | Session 12: Heart failure
Chairs: Roy Gardner & Rajdeep Khattar
13:30Prevention of heart failurePardeep Jhund, Glasgow 
13:50The different forms of heart failureAigul Baltabaeva, London 
14:10Comorbidities of heart failureMark C. Petrie, Glasgow 
14:30Iron deficienca nd heart failurePaul Kalra, Portsmouth 
14:50Management of heart failure:
the 2021 and 2023 ESC guidelines   
Theresa McDonagh, London 
15:10Panel discussion 
16:00 | Hands-on seminars
Diagnosing MASLD with
abdominal ultrasound
Kevin Moore, London 
Diagnosing heart failure with
Rajdeep Khattar, London 
17:00 | End of day 4
The programme may be subject to change.

Industry Sponsored Symposium

Thursday, May 2nd, 2024

12:30 Challenging the Status Quo in Cardiorenal Management
This is a promotional symposium sponsored and organised by AstraZeneca, intended for GB HCPs only
Professor Derek Connolly, BSc[Hons] MB ChB[Edin] PhD[Cantab] DSc[Hon] FRCP FRCPE FESC, Consultant Cardiologist, Birmingham City & Sandwell Hospitals
Dr Kate Bramham, Reader of Nephrology & Maternal Medicine and Honorary Consultant Nephrologist, King’s College London

General Information

Registration fees 
Regular feeGBP 950
Early registration fee (until March 1, 2024)GBP 850
Trainees/Residents, Research fellows, Nurses, Students
<40 years (ID proof required)*
GPB 700
Day TicketsGPB 240

*For the reduced registration (Trainees/Residents, Research fellows, Nurses, Students <40 years) please send a copy of your ID to Ms. Christine Lohmann at

Registration will be confirmed upon receipt of payment.
Please note that UK banks may charge high fees for international bank transfers. We therefore recommend payment by credit card.

Modification & Cancellation

All modifications or cancellations must be notified in writing (by mail, fax or e-mail) to Zurich Heart House. For each modification requested by the participant, GBP 15 will be charged for administrative costs. In case of cancellation up to March 31st, 2024, deposits will be refunded less 35% for administrative costs. After this date, no refund will be possible.


The Royal Society of Medicine,
1 Wimpole St, Marylebone, London W1G 0AE, United Kingdom


Zurich Heart House, Foundation for Cardiovascular Research
Dr. Ruth Amstein
Christine Lohmann
Hottingerstrasse 14, CH-8032 Zurich, Switzerland
Phone +41 (0) 44 250 40 95, Fax +41 (0) 44 250 40 90


The Postgraduate Course in Cardiometabolic Medicine has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 26 category 1 (external) CPD credit(s).

The Postgraduate Course in Cardiometabolic Medicine has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) for a maximum of 26 European CME Credits (ECMECs).

Teaching Faculty

William Alazawi
Queen Mary University of London
London, UK

Britta George
University hospital Zurich
Zurich CH

Charalambos Antoniades
University of Oxford
Oxford, UK

Roy S. Gardner
Golden Jubilee National Hospital
Clydebank/Glasgow, UK

Aigul Baltabaeva
Royal Brompton & Harefield Hospitals
London, UK

Christoph Gräni
Bern, CH

Mahmoud Barbir
Royal Brompton & Harefield Hospitals
London, UK

Tomasz Guzik
University of Edinburgh
Edinburgh, UK

Hans-Jürg Beer
Cantonal hospital Baden
Baden, CH

Shouvik Haldar
Royal Brompton & Harefield Hospitals
London, UK

Stefan Bornstein
University hospital Dresden
Dresden, DE

Adrian Heald
University of Manchester
Manchester, UK

Kate Bramham
King’s College London
London, UK

Christian Heiss
University of Surrey
Guildford, UK

Robert Byrne
Mater Private Network Dublin Hospital
Dublin, IE

Stephan Jacob
Practice for prevention and therapy
Villingen-Schwenningen, DE

A. John Camm
St. George’s University Hospital
London, UK

Pardeep Jhund
University of Glasgow
Glasgow, UK

John Chapman
Hôpital de la Pitié
Paris, FR

Paul Kalra
Portsmouth Hospitals NHS Trust
Portsmouth, UK

Derek Connolly
Birmingham City & Sandwell Hospitals
Birmingham, UK

Vikas Kapil
Queen Mary University of London
London, UK

John E. Deanfield
University College London
London, UK

Rajdeep Khattar
Royal Brompton & Harefield Hospitals
London, UK

Marc Donath
University hospital Basel
Basel, CH

Kamlesh Khunti
University of Leicester
Leicester, UK

João Pedro Ferreira
University of Porto
Porto, PT

Andrew Krentz
King’s College London
London, UK

Michael Lean
University of Glasgow
Glasgow, UK

Francesco Rubino
King’s College London
London UK

Thomas F. Lüscher
Royal Brompton & Harefield Hospitals
London, UK

Naveed Sattar
University of Glasgow
Glasgow, UK

François Mach
University hospital Geneva,
Geneva, CH

Joanne Senior
Royal Brompton & Harefield Hospitals
Harefield, UK

Theresa McDonagh
King’s College Hospital
London, UK

Michele Senni
ASST Papa Giovanni XXIII Hospital
Bergamo, IT

Kevin Moore
University College London
London, UK    

Rakesh Sharma
Royal Brompton & Harefield Hospitals
London, UK

Barbara McGowan
Guy’s and St Thomas’ NHS Foundation Trust
London, UK

Thimoteus Speer
Goethe- University
Frankfurt am Main, DE

Geltrude Mingrone
King’s College London
London, UK

Lale Tokgözoğlu
Hacettepe University
Ankara, TR

Dirk Müller-Wieland
University hospital Aachen
Aachen, DE

Frank L.J. Visseren
Utrecht Medical Center
Utrecht, NL

Philip Newsome
University of Birmingham
Birmingham, UK

Christoph Wanner
University hospital Würzburg
Würzburg, DE

Børge Nordestgaard
Copenhagen University Hospital
Copenhagen, DK    

Christian Weber
Ludwig-Maximilians-University Munich
Munich, DE

Michael Papadakis
St. George’s University Hospitals
London, UK    

Ashutosh Wechalekar
Royal Free Hospital
London, UK

Bertram Pitt
University of Michigan
Ann Arbor, US    

David C. Wheeler
University College London
London, UK

Alison Pottle
Royal Brompton & Harefield Hospitals
Harefield, UK

Eleanor Wicks
University of Oxford
Oxford, UK

Kausik Ray
Imperial College London
London, UK 


Under the Auspices of

In collaboration with